Home  /  Resource Library  /  Lenalidomide-rituximab with high-dose methotrexate for treatment of patients with newly diagnosed primary cns lymphoma: a promising first-line approach

Lenalidomide-rituximab with high-dose methotrexate for treatment of patients with newly diagnosed primary cns lymphoma: a promising first-line approach

Results of a study investigating lenalidomide, rituximab and methotrexate for treatment of PCNSL.